We studied the effect of an indolinone derivative GRS on the development of experimental atherosclerosis in C57BL/6 mice. Atherosclerosis was modeled by intraperitoneal administration of endothelial lipoprotein lipase inhibitor Kolliphor P 407 micro Geismar over 5 months. GRS was administered orally in a dose of 10 mg/kg once a day throughout the experiment. In 5 months, the levels of total cholesterol, LDL, and triglycerides in blood serum, as well as histological composition of the ascending aorta were studied. In mice with experimental atherosclerosis, we observed pronounced dyslipidemia with an increase in serum cholesterol, LDL, and triglycerides and accumulation of xanthoma cells in the aorta wall. Repeat administration of GRS did not eliminate dyslipidemia, but prevented an increase in the number of xanthoma cells in the aorta wall (p<0.05). The stimulator of soluble guanylate cyclase GRS did not exhibit hypolipidemic activity, but restored impaired endothelial function in the atherosclerosis model and prevented atherosclerotic damage to blood vessels and vascular wall remodeling.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Russia in Figures 2019: Statistical Handbook. Moscow, 2019. Russian.
Kukharchuk VV, Ezhov MV, Sergienko IV, Arabidze GG, Bubnova MG, Balakhonova TV, Gurevich VS, Kachkovsky MA, Konovalov GA, Konstantinov VO, Malyshev PP, Pokrovsky SN, Sokolov AA, Sumarokov AB, Gornyakova NB, Obrezan AG, Shaposhnik II, Ansheles AA, Aronov DM, Akhmedzhanov NM, Barbarash OL, Boitsov SA, Voevoda MI, Galstyan GR, Galyavich AS, Drapkina OM, Duplyakov DV, Karpov RS, Karpov YuA, Koziolova NA, Nebieridze DV, Nedogoda SV, Oleinikov VE, Ragino YuI, Skibitsky VV, Smolenskaya OG, Filippov AE, Khalimov YuSh, Chazova IE, Shestakova MV, Yakushin SS. Diagnostics and correction of lipid metabolism disorders in order to prevent and treat atherosclerosis. Russian recommendations, VII revision. Ateroskleroz Dislipidemiya. 2020;(1):7-40. Russian. doi: https://doi.org/10.34687/2219-8202.JAD.2020.01.0002
Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(23, Suppl 1):III27-III 32. doi: https://doi.org/10.1161/01.CIR.0000131515.03336.f8
Makhoul S, Walter E, Pagel O, Walter U, Sickmann A, Gambaryan S, Smolenski A, Zahedi RP, Jurk K. Effects of the NO/soluble guanylate cyclase/cGMP system on the functions of human platelets. Nitric Oxide. 2018;76:71-80. doi: https://doi.org/10.1016/j.niox.2018.03.008
Bykov VV, Smol’yakova VI, Chernysheva GA, Aliev OI, Anishchenko AM, Sidekhmenova AV, Dunaeva OI, Stankevich SA, Khazanov VA. Effects of a New Antithrombotic Drug GRS, a Soluble Guanylate Cyclase Stimulator, on Endothelial Dysfunction in Rats with Myocardial Infarction. Bull. Exp. Biol. Med. 2022;172(6):709-712. doi: https://doi.org/10.1007/s10517-022-05461-y
Bykov VV, Chernysheva GA, Smolyakova VI, Serebrov VYu, Khazanov VA, Udut VV. Antiplatelet activity of a new indolinone derivative. Eksper. Klin. Farmakol. 2019;82(7):10-13. Russian. doi: https://doi.org/10.30906/0869-2092-2019-82-7-10-13
Park J, Yeom M, Hahm DH. Fucoidan improves serum lipid levels and atherosclerosis through hepatic SREBP-2-mediated regulation. J. Pharmacol. Sci. 2016;131(2):84-92. doi: https://doi.org/10.1016/j.jphs.2016.03.007
Manskikh VN. Technical aspects. General and organ pathology. Pathomorphology of the Laboratory Mouse (in 3 vol.). Vol. I. Moscow, 2016. Russian.
Manskikh VN. Atlas. Pathomorphology of the Laboratory Mouse (in 3 vol.). Vol. III. Moscow, 2017. Russian.
Yao BC, Meng LB, Hao ML, Zhang YM, Gong T, Guo ZG. Chronic stress: a critical risk factor for atherosclerosis. J. Int. Med. Res. 2019;47(4):1429-1440. doi: https://doi.org/10.1177/0300060519826820
Monteiro S, Roque S, de Sá-Calçada D, Sousa N, Correia-Neves M, Cerqueira JJ. An efficient chronic unpredictable stress protocol to induce stress-related responses in C57BL/6 mice. Front. Psychiatry. 2015;6:6. doi: https://doi.org/10.3389/fpsyt.2015.00006
Krivolapov YuA, Leenman EE. Morphological Diagnosis of Lymphomas. St. Petersburg, 2006. Russian.
Mishra P, Pandey CM, Singh U, Keshri A, Sabaretnam M. Selection of appropriate statistical methods for data analysis. Ann. Card Anaesth. 2019;22(3):297-301. doi: https://doi.org/10.4103/aca.ACA_248_18
Correia SS, Liu G, Jacobson S, Bernier SG, Tobin JV, Schwartzkopf CD, Atwater E, Lonie E, Rivers S, Carvalho A, Germano P, Tang K, Iyengar RR, Currie MG, Hadcock JR, Winrow CJ, Jones JE. The CNS-penetrant soluble guanylate cyclase stimulator CYR119 attenuates markers of inflammation in the central nervous system. J. Neuroinflammation. 2021;18(1):213. doi: https://doi.org/10.1186/s12974-021-02275-z
Brusilovskaya K, Königshofer P, Lampach D, Szodl A, Supper P, Bauer D, Beer A, Stift J, Timelthaler G, Oberhuber G, Podesser BK, Seif M, Zinober K, Rohr-Udilova N, Trauner M, Reiberger T, Schwabl P. Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats. United European Gastroenterol. J. 2020;8(10):1174-1185. doi: https://doi.org/10.1177/2050640620944140
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 174, No. 9, pp. 319-323, September 2022
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bykov, V.V., Bykova, A.V., Dzyuman, A.N. et al. Anti-Atherosclerotic Action of a New Stimulator of Soluble Guanylate Cyclase in an Experiment. Bull Exp Biol Med 174, 333–336 (2023). https://doi.org/10.1007/s10517-023-05703-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-023-05703-7